<DOC>
	<DOC>NCT00687271</DOC>
	<brief_summary>The purpose of this study is to test the safety and effectiveness of MK6213 as compared to MK6213/Atorvastatin in patients (18 to 75 years) with high cholesterol.</brief_summary>
	<brief_title>A Study of MK6213 Co-Administered With Atorvastatin in Patients With Hypercholesterolemia (MK-6213-006)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Patient is 18 to 75 years of age at the time of the study with high cholesterol can have diabetes mellitus but is not currently on lipid lowering therapy have a stable weight for &gt;6 weeks Patient has significant cardiovascular (heart), renal (kidney), neurologic (nervous system), respiratory (lung), hepatic (liver) or metabolic disease history of mental instability or drug/alcohol abuse within the past 5 years pregnant or nursing; HIV positive; history of cancer within the past 5 years or participation in an investigational trial within the last 30 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>